Amgen ROE - Return on Equity 2010-2024 | AMGN

Amgen return on equity for the quarter ending September 30, 2024 was 68.49.

  • Amgen average return on equity for 2023 was 151.62, a 11.47% decline from 2022.
  • Amgen average return on equity for 2022 was 171.26, a 156.53% decline from 2021.
  • Amgen average return on equity for 2021 was 66.76, a 8.11% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

Amgen ROE - Return on Equity 2010-2024 | AMGN

  • Amgen average return on equity for 2023 was 151.62, a 11.47% decline from 2022.
  • Amgen average return on equity for 2022 was 171.26, a 156.53% decline from 2021.
  • Amgen average return on equity for 2021 was 66.76, a 8.11% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.